| |
|
|
 |
- Address:
- 3005 First Avenue
Seattle, WA 98121
- Phone:
- (206) 256-4545
- Website:
- http://www.dendreon.com
-
- Company Information:
-
Dendreon Corporation is located at Seattle, WA and is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Through innovative science and technology, we are striving to develop and commercialize products that address unmet medical need, improve survival and have a favorable safety profile. Our active immunotherapy, monoclonal antibody and small molecule development capabilities provide us with a solid foundation on which to build a variety of oncology treatments that meet these objectives.
Our lead product candidate, sipuleucel-T an investigational active cellular immunotherapy for the treatment of prostate cancer, is in late-stage Phase 3 clinical development to evaluate its safety and potential effectiveness in advanced prostate cancer.
We believe that transforming the treatment of cancer will benefit patients and create value for stockholders. Our business strategy is to develop products that are well-tolerated, provide clinical benefit and address unmet medical need; maximize the speed to market of lead active immunotherapies; build a large and diverse product portfolio; retain core commercialization rights; develop key collaborative agreements; and effectively leverage proprietary technologies.
Everyone at Dendreon is aware of the importance of our work to the millions of lives touched by cancer worldw
|
 |
|
|
